UnknownNCT00252044

Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder

This study has public registry information. It focuses on personality disorders and currently lists study information in the United States.

Personality disorders, Personality disorders, ...DrugFrom 18 Years to 60 Years

The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 60 years.

Listed locations: New York, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateOctober 2000

Recruitment status: Unknown
Enrollment listed in the registry: Not clearly listed
Sponsor: Bronx VA Medical Center
Sponsor type: Hospital / academic medical center
Study type: Drug
Intervention type: Medication / drug
Study phase: Not clearly listed
Locations: United States
Age range: From 18 Years to 60 Years
Official registry ID: NCT00252044
Official title: The Dopaminergic System in Schizotypal Personality Disorder: Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Study ID: NCT00252044. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Status unknown

New York

Registry details

Registry conditions (original wording)

Schizotypal Personality Disorder; Other Personality Disorders

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Bronx VA Medical Center, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Pergolide.

Who can participate?

Listed age limits: 18 years to 60 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me